Dynavax Technologies Statistics
Total Valuation
DVAX has a market cap or net worth of $1.76 billion. The enterprise value is $1.40 billion.
Important Dates
The next estimated earnings date is Thursday, February 19, 2026, after market close.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DVAX has 113.68 million shares outstanding. The number of shares has decreased by -7.72% in one year.
| Current Share Class | 113.68M |
| Shares Outstanding | 113.68M |
| Shares Change (YoY) | -7.72% |
| Shares Change (QoQ) | -1.36% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 85.37% |
| Float | 97.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.55 |
| PS Ratio | 5.73 |
| Forward PS | 4.49 |
| PB Ratio | 3.40 |
| P/TBV Ratio | 3.31 |
| P/FCF Ratio | 21.85 |
| P/OCF Ratio | 19.42 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 57.88, with an EV/FCF ratio of 17.40.
| EV / Earnings | n/a |
| EV / Sales | 4.24 |
| EV / EBITDA | 57.88 |
| EV / EBIT | 72.52 |
| EV / FCF | 17.40 |
Financial Position
The company has a current ratio of 7.62, with a Debt / Equity ratio of 0.54.
| Current Ratio | 7.62 |
| Quick Ratio | 6.78 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 10.45 |
| Debt / FCF | 3.59 |
| Interest Coverage | 2.89 |
Financial Efficiency
Return on equity (ROE) is -7.14% and return on invested capital (ROIC) is 11.18%.
| Return on Equity (ROE) | -7.14% |
| Return on Assets (ROA) | 1.20% |
| Return on Invested Capital (ROIC) | 11.18% |
| Return on Capital Employed (ROCE) | 2.30% |
| Weighted Average Cost of Capital (WACC) | 8.12% |
| Revenue Per Employee | $816,084 |
| Profits Per Employee | -$107,163 |
| Employee Count | 405 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.87 |
Taxes
In the past 12 months, DVAX has paid $2.79 million in taxes.
| Income Tax | 2.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.63% in the last 52 weeks. The beta is 0.89, so DVAX's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +19.63% |
| 50-Day Moving Average | 13.17 |
| 200-Day Moving Average | 11.05 |
| Relative Strength Index (RSI) | 77.05 |
| Average Volume (20 Days) | 3,471,086 |
Short Selling Information
The latest short interest is 10.62 million, so 9.34% of the outstanding shares have been sold short.
| Short Interest | 10.62M |
| Short Previous Month | 12.29M |
| Short % of Shares Out | 9.34% |
| Short % of Float | 10.93% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, DVAX had revenue of $330.51 million and -$43.40 million in losses. Loss per share was -$0.36.
| Revenue | 330.51M |
| Gross Profit | 203.60M |
| Operating Income | 19.32M |
| Pretax Income | -40.61M |
| Net Income | -43.40M |
| EBITDA | 24.21M |
| EBIT | 19.32M |
| Loss Per Share | -$0.36 |
Full Income Statement Balance Sheet
The company has $647.82 million in cash and $289.22 million in debt, with a net cash position of $358.59 million or $3.15 per share.
| Cash & Cash Equivalents | 647.82M |
| Total Debt | 289.22M |
| Net Cash | 358.59M |
| Net Cash Per Share | $3.15 |
| Equity (Book Value) | 534.14M |
| Book Value Per Share | 4.55 |
| Working Capital | 707.49M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $90.63 million and capital expenditures -$10.10 million, giving a free cash flow of $80.54 million.
| Operating Cash Flow | 90.63M |
| Capital Expenditures | -10.10M |
| Free Cash Flow | 80.54M |
| FCF Per Share | $0.71 |
Full Cash Flow Statement Margins
Gross margin is 61.60%, with operating and profit margins of 5.85% and -13.13%.
| Gross Margin | 61.60% |
| Operating Margin | 5.85% |
| Pretax Margin | -12.29% |
| Profit Margin | -13.13% |
| EBITDA Margin | 7.33% |
| EBIT Margin | 5.85% |
| FCF Margin | 24.37% |
Dividends & Yields
DVAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.72% |
| Shareholder Yield | 7.72% |
| Earnings Yield | -2.47% |
| FCF Yield | 4.58% |
Analyst Forecast
The average price target for DVAX is $26.50, which is 71.19% higher than the current price. The consensus rating is "Hold".
| Price Target | $26.50 |
| Price Target Difference | 71.19% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 14.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 10, 2014. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 10, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
DVAX has an Altman Z-Score of 2.01 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 5 |